Skip to main content
. Author manuscript; available in PMC: 2015 May 15.
Published in final edited form as: Cancer. 2014 Feb 27;120(10):1586–1593. doi: 10.1002/cncr.28619

Table 5.

Total, Free, and Bioavailable Testosterone Association with Survival in Male Patients with Advanced Cancer

Testosterone Test
(ng/dL)		 Tertile1
Low
Median Survival
Days (Q1-Q3)		 Tertile2
Middle
Median Survival
Days (Q1-Q3)		 Tertile3
High
Median Survival
Days (Q1-Q3)		 p-value
Total Testosterone 92 (66.3–117.7) 240 (122.7–357.3) 174 (112.0–235.0) 0.002
Free Testosterone 95 (47.0–143.0) 150 (11.00–189.0) 210 (71.90–348.0) 0.089
Bio-available Testosterone 86 (49.6–122.4) 174 (71.50–276.5) 280 (151.2–408.8) 0.016